BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guan MC, Ouyang W, Wang MD, Liang L, Li N, Fu TT, Shen F, Lau WY, Xu QR, Huang DS, Zhu H, Yang T. Biomarkers for hepatocellular carcinoma based on body fluids and feces. World J Gastrointest Oncol 2021; 13(5): 351-365 [PMID: 34040698 DOI: 10.4251/wjgo.v13.i5.351] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Pallozzi M, Di Tommaso N, Maccauro V, Santopaolo F, Gasbarrini A, Ponziani FR, Pompili M. Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives. Cancers 2022;14:4631. [DOI: 10.3390/cancers14194631] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Dou J, Dawuti W, Zheng X, Zhang R, Zhou J, Lin R, Lü G. Urine Fluorescence spectroscopy combined with machine learning for screening of hepatocellular carcinoma and liver cirrhosis. Photodiagnosis Photodyn Ther 2022;:103102. [PMID: 36057362 DOI: 10.1016/j.pdpdt.2022.103102] [Reference Citation Analysis]
3 Guan M, Wang M, Wang W, Li C, Yao L, Zhu H, Yang T. Exosomes as mediators of tumor immune escape and immunotherapy in hepatocellular carcinoma. Liver Research 2022. [DOI: 10.1016/j.livres.2022.08.001] [Reference Citation Analysis]
4 Nath LR, Murali M, Nair B. Critical biomarkers of hepatocellular carcinoma in body fluids and gut microbiota. World J Gastrointest Oncol 2021; 13(12): 2219-2222 [DOI: 10.4251/wjgo.v13.i12.2219] [Reference Citation Analysis]
5 Zamora-León SP. Hepatocellular carcinoma biomarkers, an imminent need. World J Gastrointest Oncol 2021; 13(11): 1847-1849 [PMID: 34853655 DOI: 10.4251/wjgo.v13.i11.1847] [Reference Citation Analysis]